FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313264885> ?p ?o ?g. }

• W4313264885 endingPage "775" @default.
• W4313264885 startingPage "768" @default.
• W4313264885 abstract "Background: The opioid analgesic hydromorphone has a low renal excretion ratio; however, exposure after oral administration is several times higher in those with moderate or severe renal impairment. Objectives: We evaluated the impact of renal impairment on the steady-state pharmacokinetics of intravenously administered hydromorphone in patients with cancer being treated for pain. Design: This was an open-label, prospective, parallel-comparison, interventional clinical pharmacology study. Setting/Subjects: This study was conducted at one hospital in Japan. Using creatinine clearance (CLcr) values, patients were grouped according to kidney function: CLcr ≥90 mL/min (normal), 60-<90 mL/min (mild impairment), 30-<60 mL/min (moderate impairment), or <30 mL/min (severe impairment). Measurements: Hydromorphone was administered by constant infusion to patients at the same constant dose rate as at the time of enrollment. Hydromorphone and its glucuronide metabolite concentrations in plasma and urine were measured by liquid chromatography-mass spectrometry. Pharmacokinetic parameters at steady state were assessed using noncompartmental analysis. Results: Thirty-two patients were enrolled (normal, n = 3; mild, n = 10; moderate, n = 15; and severe, n = 4). Adjusted geometric mean ratios for hydromorphone steady-state clearance (CLss) for patients with impaired versus normal renal function were 0.69 (90% confidence interval [CI], 0.41-1.14), 0.52 (90% CI, 0.31-0.84), and 0.55 (90% CI, 0.30-1.02) for mild, moderate, or severe impairment, respectively. Exposures to the metabolite hydromorphone-3-glucuronide generally increased with renal impairment. No adverse event was reported. Conclusion: Hydromorphone CLss in patients with impaired renal function (moderate and severe) was decreased ∼50% of that of normal renal function." @default.
• W4313264885 created "2023-01-06" @default.
• W4313264885 creator A5004599472 @default.
• W4313264885 creator A5032729131 @default.
• W4313264885 creator A5033686030 @default.
• W4313264885 creator A5048214676 @default.
• W4313264885 creator A5059157227 @default.
• W4313264885 creator A5068428660 @default.
• W4313264885 creator A5077440505 @default.
• W4313264885 creator A5091554378 @default.
• W4313264885 date "2023-06-01" @default.
• W4313264885 modified "2023-10-14" @default.
• W4313264885 title "Steady-State Pharmacokinetics of Intravenous Hydromorphone in Japanese Patients With Renal Impairment and Cancer Pain" @default.
• W4313264885 cites W1965994121 @default.
• W4313264885 cites W1972842876 @default.
• W4313264885 cites W199624722 @default.
• W4313264885 cites W2006880847 @default.
• W4313264885 cites W2012411484 @default.
• W4313264885 cites W2017586519 @default.
• W4313264885 cites W2035473666 @default.
• W4313264885 cites W2038196778 @default.
• W4313264885 cites W2072094974 @default.
• W4313264885 cites W2096716094 @default.
• W4313264885 cites W2107448778 @default.
• W4313264885 cites W2108802610 @default.
• W4313264885 cites W2109202199 @default.
• W4313264885 cites W2161943291 @default.
• W4313264885 cites W2163923079 @default.
• W4313264885 cites W2337210803 @default.
• W4313264885 cites W2528553606 @default.
• W4313264885 cites W2582602949 @default.
• W4313264885 cites W2803371211 @default.
• W4313264885 cites W2834719472 @default.
• W4313264885 cites W286607158 @default.
• W4313264885 cites W3084140385 @default.
• W4313264885 cites W4211214267 @default.
• W4313264885 doi "https://doi.org/10.1089/jpm.2022.0289" @default.
• W4313264885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36579915" @default.
• W4313264885 hasPublicationYear "2023" @default.
• W4313264885 type Work @default.
• W4313264885 citedByCount "0" @default.
• W4313264885 crossrefType "journal-article" @default.
• W4313264885 hasAuthorship W4313264885A5004599472 @default.
• W4313264885 hasAuthorship W4313264885A5032729131 @default.
• W4313264885 hasAuthorship W4313264885A5033686030 @default.
• W4313264885 hasAuthorship W4313264885A5048214676 @default.
• W4313264885 hasAuthorship W4313264885A5059157227 @default.
• W4313264885 hasAuthorship W4313264885A5068428660 @default.
• W4313264885 hasAuthorship W4313264885A5077440505 @default.
• W4313264885 hasAuthorship W4313264885A5091554378 @default.
• W4313264885 hasBestOaLocation W43132648851 @default.
• W4313264885 hasConcept C112705442 @default.
• W4313264885 hasConcept C126322002 @default.
• W4313264885 hasConcept C126894567 @default.
• W4313264885 hasConcept C149151106 @default.
• W4313264885 hasConcept C159641895 @default.
• W4313264885 hasConcept C170493617 @default.
• W4313264885 hasConcept C2777477808 @default.
• W4313264885 hasConcept C2779158186 @default.
• W4313264885 hasConcept C2780026642 @default.
• W4313264885 hasConcept C2780820201 @default.
• W4313264885 hasConcept C2781063702 @default.
• W4313264885 hasConcept C2908822073 @default.
• W4313264885 hasConcept C42219234 @default.
• W4313264885 hasConcept C44249647 @default.
• W4313264885 hasConcept C71924100 @default.
• W4313264885 hasConceptScore W4313264885C112705442 @default.
• W4313264885 hasConceptScore W4313264885C126322002 @default.
• W4313264885 hasConceptScore W4313264885C126894567 @default.
• W4313264885 hasConceptScore W4313264885C149151106 @default.
• W4313264885 hasConceptScore W4313264885C159641895 @default.
• W4313264885 hasConceptScore W4313264885C170493617 @default.
• W4313264885 hasConceptScore W4313264885C2777477808 @default.
• W4313264885 hasConceptScore W4313264885C2779158186 @default.
• W4313264885 hasConceptScore W4313264885C2780026642 @default.
• W4313264885 hasConceptScore W4313264885C2780820201 @default.
• W4313264885 hasConceptScore W4313264885C2781063702 @default.
• W4313264885 hasConceptScore W4313264885C2908822073 @default.
• W4313264885 hasConceptScore W4313264885C42219234 @default.
• W4313264885 hasConceptScore W4313264885C44249647 @default.
• W4313264885 hasConceptScore W4313264885C71924100 @default.
• W4313264885 hasIssue "6" @default.
• W4313264885 hasLocation W43132648851 @default.
• W4313264885 hasLocation W43132648852 @default.
• W4313264885 hasLocation W43132648853 @default.
• W4313264885 hasOpenAccess W4313264885 @default.
• W4313264885 hasPrimaryLocation W43132648851 @default.
• W4313264885 hasRelatedWork W1964759623 @default.
• W4313264885 hasRelatedWork W2011005335 @default.
• W4313264885 hasRelatedWork W2017357698 @default.
• W4313264885 hasRelatedWork W2021281327 @default.
• W4313264885 hasRelatedWork W2034253677 @default.
• W4313264885 hasRelatedWork W2042399818 @default.
• W4313264885 hasRelatedWork W2132691174 @default.
• W4313264885 hasRelatedWork W2161804721 @default.
• W4313264885 hasRelatedWork W2413221923 @default.
• W4313264885 hasRelatedWork W1924049245 @default.
• W4313264885 hasVolume "26" @default.

• next